The Ministry of Health and Family Welfare has issued a Gazette notification mandating that oral medicines containing more than 12 percent alcohol content and packaged in bottles exceeding 30 milliliters will now require a doctor's prescription for purchase. This amendment to the Drugs and Cosmetics Act removes these products from a category that previously allowed easier sale without prescription.
Background of the Amendment
Previously, certain oral medicines such as cough syrups and bitters with high alcohol content were classified under a less restrictive category, enabling their over-the-counter sale. The new rule aims to curb potential misuse and health risks associated with unsupervised consumption of alcohol-rich medicines. According to the Ministry, the change is part of broader efforts to regulate substances that can lead to liver dysfunction and other diseases.
Impact on Public Health
Health experts have welcomed the move, citing concerns about liver damage and addiction. Dr. Ananya Sharma, a hepatologist at AIIMS, stated, "Unregulated sale of high-alcohol syrups has been linked to cases of liver dysfunction, especially among individuals unaware of the alcohol content." The notification emphasizes that patients must now present a valid prescription from a registered medical practitioner before purchasing these medicines in larger pack sizes.
Scope of the Regulation
The amendment applies to all oral liquid preparations, including syrups and bitters, that exceed 12 percent alcohol by volume. Products in containers of 30ml or less remain exempt from the prescription requirement, as they are considered for single or limited use. The Ministry clarified that the rule does not affect topical or injectable medications.
Industry Response
Pharmaceutical companies have expressed mixed reactions. Some manufacturers argue that the move may inconvenience patients who rely on these medicines for chronic conditions. However, the Ministry maintains that public health priorities outweigh convenience, noting that similar regulations exist internationally. The notification was published on July 10, 2026, and takes immediate effect.
